These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8981389)

  • 1. The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controls.
    Koreen AR; Lieberman JA; Alvir J; Chakos M
    Neuropsychopharmacology; 1997 Jan; 16(1):61-8. PubMed ID: 8981389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
    Abi-Saab W; Seibyl JP; D'Souza DC; Karper LP; Gueorgueva R; Abi-Dargham A; Wong ML; Rajhans S; Erdos JP; Heninger GR; Charney DS; Krystal JH
    Psychopharmacology (Berl); 2002 Jun; 162(1):55-62. PubMed ID: 12107618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.
    Pigott TA; Hill JL; Grady TA; L'Heureux F; Bernstein S; Rubenstein CS; Murphy DL
    Biol Psychiatry; 1993 Jan; 33(1):3-14. PubMed ID: 8420593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral response to methylphenidate and treatment outcome in first episode schizophrenia.
    Jody D; Lieberman JA; Geisler S; Szymanski S; Alvir JM
    Psychopharmacol Bull; 1990; 26(2):224-30. PubMed ID: 2236460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
    Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E
    Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
    Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS
    Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats.
    Baumann MH; Rutter JJ; Auerbach SB
    Neuropharmacology; 1993 Dec; 32(12):1381-6. PubMed ID: 8152528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low versus standard dose mCPP challenge in obsessive-compulsive patients.
    Erzegovesi S; Martucci L; Henin M; Bellodi L
    Neuropsychopharmacology; 2001 Jan; 24(1):31-6. PubMed ID: 11106873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers.
    Maes M; Meltzer HY
    Psychiatry Res; 1996 Oct; 64(3):147-59. PubMed ID: 8944393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion.
    Ghaziuddin N; King CA; Welch KB; Zaccagnini J; Weidmer-Mikhail E; Mellow AM; Ghaziuddin M; Greden JF
    Psychiatry Res; 2000 Sep; 95(3):183-94. PubMed ID: 10974357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin function and treatment response to clozapine in schizophrenic patients.
    Kahn RS; Davidson M; Siever L; Gabriel S; Apter S; Davis KL
    Am J Psychiatry; 1993 Sep; 150(9):1337-42. PubMed ID: 8394651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.
    Kahn RS; Siever LJ; Gabriel S; Amin F; Stern RG; DuMont K; Apter S; Davidson M
    Psychiatry Res; 1992 Jul; 43(1):1-12. PubMed ID: 1332094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation.
    D'Souza DC; Gil RB; Zuzarte E; MacDougall LM; Donahue L; Ebersole JS; Boutros NN; Cooper T; Seibyl J; Krystal JH
    Biol Psychiatry; 2006 Jan; 59(2):128-37. PubMed ID: 16140281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.
    Goodman WK; McDougle CJ; Price LH; Barr LC; Hills OF; Caplik JF; Charney DS; Heninger GR
    Biol Psychiatry; 1995 Aug; 38(3):138-49. PubMed ID: 7578657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP).
    Price LH; Malison RT; McDougle CJ; McCance-Katz EF; Owen KR; Heninger GR
    Neuropsychopharmacology; 1997 Nov; 17(5):342-50. PubMed ID: 9348549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cortical reorganization on the effect of 5-HT pharmacotherapy for spinal cord injury.
    Moxon KA; Kao T; Shumsky JS
    Exp Neurol; 2013 Feb; 240():17-27. PubMed ID: 23159333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety.
    Gatch MB
    Life Sci; 2003 Aug; 73(11):1347-67. PubMed ID: 12850497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
    Iqbal N; Asnis GM; Wetzler S; Kahn RS; Kay SR; van Praag HM
    Biol Psychiatry; 1991 Oct; 30(8):770-8. PubMed ID: 1751620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.